abstract |
The present invention relates to biological materials related to c-Met possibly in combination with VEGF and/or EGFR, and more in particuiar to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions and in particuiar to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. |